Australia Thyroid Cancer Diagnostics Market Size & Outlook
Australia thyroid cancer diagnostics market, 2018-2030 (US$M)
Related Markets
Australia thyroid cancer diagnostics market highlights
- The Australia thyroid cancer diagnostics market generated a revenue of USD 62.5 million in 2019 and is expected to reach USD 113.7 million by 2027.
- The Australia market is expected to grow at a CAGR of 7.8% from 2020 to 2027.
- In terms of segment, papillary carcinoma was the largest revenue generating type in 2019.
- Follicular Carcinoma is the most lucrative type segment registering the fastest growth during the forecast period.
Thyroid cancer diagnostics market data book summary
| Market revenue in 2019 | USD 62.5 million |
| Market revenue in 2027 | USD 113.7 million |
| Growth rate | 7.8% (CAGR from 2019 to 2027) |
| Largest segment | Papillary carcinoma |
| Fastest growing segment | Follicular Carcinoma |
| Historical data | 2016 - 2018 |
| Base year | 2019 |
| Forecast period | 2020 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Papillary Carcinoma, Follicular Carcinoma |
| Key market players worldwide | Abbott Laboratories, Roche, Thermo Fisher Scientific Inc, Siemens Healthineers AG ADR, Bio-Rad Laboratories Inc, GE Aerospace, Koninklijke Philips NV, Toshiba Corporation, Agilent Technologies Inc, Illumina Inc |
Other key industry trends
- In terms of revenue, Australia accounted for 2.5% of the global thyroid cancer diagnostics market in 2019.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
- In Asia Pacific, Japan thyroid cancer diagnostics market is projected to lead the regional market in terms of revenue in 2027.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 102.1 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Thyroid Cancer Diagnostics Market Scope
Thyroid Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia thyroid cancer diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to thyroid cancer diagnostics market will help companies and investors design strategic landscapes.
Papillary carcinoma was the largest segment with a revenue share of 80.64% in 2024. Horizon Databook has segmented the Australia thyroid cancer diagnostics market based on papillary carcinoma, follicular carcinoma covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Australia thyroid cancer diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia thyroid cancer diagnostics market databook
-
Our clientele includes a mix of thyroid cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia thyroid cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Australia thyroid cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia thyroid cancer diagnostics market size, by type, 2018-2030 (US$M)
Australia Thyroid Cancer Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
